Author

Строкова Мария Александровна

Observed names: M. A. Strokova, Mariya A. Strokova, Строкова М.А.

Institution: Republican Oncological Clinical Dispensary

Observed institution: Republican Oncological Clinical Dispensary

ORCID: 0000-0002-3360-3401

Observed ORCID: 0000-0002-3360-3401

OpenAlex ID: A5037730371

Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study

2024 · Maria I. Volkova, Alexey S. Kalpinskiy, et al. · Journal of Modern Oncology · 2

Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma

2024 · M. I. Volkova, A. S. Kalpinskiy, et al. · Cancer Urology · 1

Microsatellite instability in endometrial cancer: the role of diagnostic methods and their clinical application. Expert consensus

2022 · A. S. Tyulyandina, E. A. Ulrikh, et al. · Tumors of female reproductive system · 1

Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study

2025 · Maria I. Volkova, Alexey S. Kalpinskiy, et al. · Journal of Modern Oncology

Эффективность и безопасность ленватиниба с пембролизумабом при распространенном почечноклеточном раке в реальной практике: обновленные данные российского наблюдательного исследования

· Волкова Мария Игоревна, Калпинский Алексей Сергеевич, et al. · CyberLeninK (CyberLeninka)

Works count: 7

Citation count: 4

H-index: 1

I10-index: